View More View Less
  • 1 Jagiellonian University Medical College, Cracow, Poland
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

The purpose of this study was to determine the activity of the autonomic nervous system (ANS), using spectral analysis of the heart rate variability (HRV) in the model of partial bladder outlet obstruction (PBOO) in rats treated with selected non-steroidal anti-inflammatory drugs (NSAID): piroxicam (PRX) or meloxicam (MLX), and following administration of PGF2a prostaglandin analogue (Enzaprost F5). Neither the use of PGF2a analogue nor of MLX, caused significant changes in the HRV spectrum (except for HRV spectrum total power reduction with MLX). The use of PRX caused reduction of the total power and powers of all components of the HRV spectrum (except for VLF). Moreover, increased nLF and reduced nHF were observed. The obtained results suggest that the total prostaglandin synthesis block with a non-selective cyclooxygenase inhibitor (PRX) results in reduced ANS total activity, with decreased parasympathetic activity and a relative sympathetic predominance. The preferential cyclooxygenase-2 block (MLX) caused reduction of the total ANS activity as well, however with no clear disproportion of any part of the ANS. Therefore, prostaglandin synthesis inhibition and associated decrease of parasympathetic activity may constitute an additional and favourable feature of NSAID pharmacodynamics in the treatment of BPH.

  • 1.

    Andersson KE, Pehrson R: CNS involvement in overactive bladder. Drugs 63, 25952611 (2003)

  • 2.

    Andersson KE: LUTS treatment: future treatment options. Neurourol. Urodyn. 26, 934947 (2007)

  • 3.

    Araki T, Yokoyama T, Kumon H: Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non randomized study of loxoprofen sodium once daily before sleeping. Acta Med. Okayama 58, 4549 (2004)

    • Search Google Scholar
    • Export Citation
  • 4.

    Arend A, Aunapuu M, Massob R, Selstam G: Prostaglandins of the E-series inhibit connective tissue proliferation in the liver wound of the rat. Ann. Anat. 187, 5762 (2005)

    • Search Google Scholar
    • Export Citation
  • 5.

    Aubert AE, Ramaekers D, Beckers F, Breem R, Denef C, Van De Werf F, Ector H: The analysis of heart rate variability in unrestrained rats. Validation of method and results. Comput. Methods Programs Biomed. 60, 197213 (1999)

    • Search Google Scholar
    • Export Citation
  • 6.

    Boon TA, Van Venrooij GE, Eckhardt MD: Effects of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients benign prostatic hyperplasia. Curr. Urol. Rep. 2, 297301 (2001)

    • Search Google Scholar
    • Export Citation
  • 7.

    Bourque SL, Adams MA, Nakatsu K, Winterborn A: Comparison of buprenorphine and meloxicam for postsurgical analgesia in rats: effects on body weight, locomotor activity, and hemodynamic parameters. J. Am. Assoc. Lab. Anim. Sci. 49, 617622 (2010)

    • Search Google Scholar
    • Export Citation
  • 8.

    Briganti A, Capitanio U, Suardi N, Gallina A, Salonia A, Bianchi M, Tutolo M, Di Girolamo V, Guazzoni G, Rigatti P, Montorsi F: Benign prostatic hyperplasia and its aetiologies. Eur. Urol. Suppl. 8, 865871 (2009)

    • Search Google Scholar
    • Export Citation
  • 9.

    Buharalioglu CK, Korkmaz B, Cuez T, Sahan-Firat S, Sari AN, Malik KU, Tunctan B: Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide. Basic Clin. Pharmacol. Toxicol. 109, 186194 (2011)

    • Search Google Scholar
    • Export Citation
  • 10.

    Clemens JQ: Basic bladder neurophysiology. Urol. Clin. North Am. 37, 487494 (2010)

  • 11.

    Coleman RA, Smith WL, Narumiya S: International Union of Pharmacology classification prostanoids receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol. Rev. 46, 205229 (1994)

    • Search Google Scholar
    • Export Citation
  • 12.

    Dobrek L, Baranowska A, Thor PJ: Heart rate variability after BRL37344, a beta-3 agonist, in experimental bladder outlet obstruction. Postepy Hig. Med. Dosw. (Online) 67, 848858 (2013)

    • Search Google Scholar
    • Export Citation
  • 13.

    Dobrek L, Thor PJ: The influence of melatonin and agomelatine on urodynamic parameters in experimental overactive bladder model – preliminary results. Postepy Hig. Med. Dosw. (Online) 65, 725733 (2011)

    • Search Google Scholar
    • Export Citation
  • 14.

    Falahatkar S, Mokhtari G, Pourreza F, Asgari SA, Kamran AN: Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. Urology 72, 813816 (2008)

    • Search Google Scholar
    • Export Citation
  • 15.

    Goncalves H, Henriques-Coelho T, Bernardes J, Rocha AP, Brandao-Nogueira A, Leite-Moreira A: Analysis of heart rate variability in a rat model of induced pulmonary hypertension. Med. Eng. Phys. 32, 746752 (2010)

    • Search Google Scholar
    • Export Citation
  • 16.

    Hernandez F, Peluffo MC, Stouffer RL, Irusta G, Tesone M: Role of the DLL4-NOTCH system in PGF2alphainduced luteolysis in the pregnant rat. Biol. Reprod. 84, 859865 (2011)

    • Search Google Scholar
    • Export Citation
  • 17.

    Ikeda M, Kawatani M, Maruyama T, Ishihama H: Prostaglandin facilitates afferent nerve activity via EP1 receptors during urinary bladder inflammation in rats. Biomed. Res. 27, 4954 (2006)

    • Search Google Scholar
    • Export Citation
  • 18.

    Ishizuka O, Mattiasson A, Andersson KE: Prostaglandin E2-iduced bladder hyperactivity in normal, conscious rats: involvement of tachykinins? J. Urol. 153, 20342038 (1995)

    • Search Google Scholar
    • Export Citation
  • 19.

    Kahokehr A, Vather R, Nixon A, Hill AG: Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials. BJU Int. 111, 304311 (2013)

    • Search Google Scholar
    • Export Citation
  • 20.

    Kibar Y, Irkilata HC, Yaman H, Onguru O, Coguplugil AE, Ergin G, Seyrek M, Yildiz O, Dayanc M: The effect of intravesical acetylsalicylic acid instillation on tissue prostaglandin levels after partial bladder outlet obstruction in rabbits. Neurourol. Urodyn. 30, 16461651 (2011)

    • Search Google Scholar
    • Export Citation
  • 21.

    Laird JMA, Herrero JF, De La Rubia GP, Cervero F: Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: central and peripheral components. Inflamm. Res. 46, 203210 (1997)

    • Search Google Scholar
    • Export Citation
  • 22.

    Lee T, Hedlund P, Newgreen D, Andersson KE: Urodynamic effects of a novel EP-1 antagonist in normal rats and rats with bladder outlet obstruction. J. Urol. 177, 15621567 (2007)

    • Search Google Scholar
    • Export Citation
  • 23.

    Lepor H: Medical treatment of benign prostatic hyperplasia. Rev. Urol. 13, 2033 (2011)

  • 24.

    Maggi CA, Meli A: Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 1: general considerations. Experientia 42, 109114 (1986)

    • Search Google Scholar
    • Export Citation
  • 25.

    Maggi CA, Meli A: Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: cardiovascular system. Experientia 42, 292297 (1986)

    • Search Google Scholar
    • Export Citation
  • 26.

    Malik M, Bigger JT, Camm AJ, Kleiger RE, Malliani A, Moss AJ, Schwartz PJ: Guidelines. Heart rate variability. Standards of measurements, physiological interpretations and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur. Heart J. 17, 354381 (1996)

    • Search Google Scholar
    • Export Citation
  • 27.

    McCafferty GP, Misajet BA, Laping NJ, Edwards RM, Thorneloe KS: Enhanced bladder capacity and reduced prostaglandin E2-mediated bladder hyperactivity in EP3 receptor knockout mice. Am. J. Physiol. Renal Physiol. 295, F507F514 (2008)

    • Search Google Scholar
    • Export Citation
  • 28.

    Michel M, de la Rosette J: Medical treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Eur. Urol. Suppl. 8, 496503 (2009)

    • Search Google Scholar
    • Export Citation
  • 29.

    Omerbegovic M: Analysis of heart rate variability and clinical implications. Med. Arh. 63, 102105 (2009)

  • 30.

    Park JM, Yang T, Arend LJ, Schnermann JB, Peters CA, Freeman MR, Briggs JP: Obstruction stimulates COX-2 expression in bladder smooth muscle cells via increased mechanical stretch. Am. J. Physiol. Renal Physiol. 276, F129F136 (1999)

    • Search Google Scholar
    • Export Citation
  • 31.

    Park JM, Yang T, Arend LJ, Smart AM, Schnermann JB, Briggs JP: Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction. Am. J. Physiol. Renal Physiol. 273, F538F544 (1997)

    • Search Google Scholar
    • Export Citation
  • 32.

    Parsons BA, Drake MJ (2011): Animal models in overactive bladder research. In: Handbook of Experimental Pharmacology, eds Andersson KE, Michel MC, Springer-Verlag Berlin, Heidelberg, pp. 1543

    • Search Google Scholar
    • Export Citation
  • 33.

    Rahnama’i MS, van Kerrebroeck PE, de Wachter SG, van Koeveringe GA: The role of prostanoids in urinary bladder physiology. Nat. Rev. Urol. 9, 283290 (2012)

    • Search Google Scholar
    • Export Citation
  • 34.

    Roehrborn CG: Benign prostatic hyperplasia: an overview. Rev. Urol. 7 suppl. 9, S3S14 (2005)

  • 35.

    Schroder A, Newgreen D, Andersson KE: Detrusor responses to prostaglandin E2 and bladder outlet obstruction in wild-type and Ep1 receptor knockout mice. J. Urol. 172, 11661170 (2004)

    • Search Google Scholar
    • Export Citation
  • 36.

    Schussler B: Comparision of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2 derivative, on the lower urinary tract in healthy women. Urol. Res. 18, 349352 (1990)

    • Search Google Scholar
    • Export Citation
  • 37.

    Shahzamani P, Takhtfooladi MA, Jahanshahi A, Sotoudeh A: Effects of dexamethasone, piroxicam and sterile aloe vera extract on the prevention of postoperative peritoneal adhesion formation in rat. Adv. Environ. Biol. 6, 28512865 (2012)

    • Search Google Scholar
    • Export Citation
  • 38.

    St. Sauver JL, Jacobson DJ, McGree ME, Lieber MM, Jacobsen SJ: Protective association between nonsteroidal anti-inflammatory drug use and measures of benign prostatic hyperplasia. Am. J. Epidemiol. 164, 760768 (2006)

    • Search Google Scholar
    • Export Citation
  • 39.

    Sztajzel J: Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med. Wkly. 134, 514522 (2004)

    • Search Google Scholar
    • Export Citation
  • 40.

    Vanderlei LCM, Pastre CM, Hoshi RA, de Carvalho TD, deGodoy MF: Basic notions of heart rate variability and its clinical applicability. Rev. Bras. Cir. Cardiovasc. 24, 205217 (2009)

    • Search Google Scholar
    • Export Citation
  • 41.

    Ventura S, Oliver VL, White CW, Xie JH, Haynes JM, Exintaris B: Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH). Br. J. Pharmacol. 163, 891907 (2011)

    • Search Google Scholar
    • Export Citation
  • 42.

    Zeng J, Pan C, Jiang C, Lindstrom S: Cause of residual urine in bladder outlet obstruction: an experimental study in the rat. J. Urol. 188, 10271032 (2012)

    • Search Google Scholar
    • Export Citation

The author instruction is available in PDF.

Please, download the file from HERE

  • Impact Factor (2016): 0.571
  • 5-year Impact Factor (2016): 0.675
  • Physiology (Medical) Quartile score (2016): Q4
  • SJR Indicator (2016): 0.276
  • H-Index (2016): H-Index (2016): 23

Language: English

Founded in 1950
Publication: One volume of four issues annually
Publication Programme: 2016: Vol. 103
Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index Expanded
  • SCOPUS

 

Subscribers can access the electronic version of every printed article.

Senior editors

Editor(s)-in-Chief: Rosivall, László

Honorary Editor(s)-in-Chief): Monos, Emil

Managing Editor(s): Bartha, Jenő; Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

      Benedek, György (Szeged)
      Benyó, Zoltán (Budapest)
      Boros, Mihály (Szeged)
      Chernoch, László (Debrecen)
      Détári, László (Budapest)
      Hamar, János (Budapest)
      Hantos, Zoltán (Szeged)
      Hunyady, László (Budapest)
      Imre, Sándor (Debrecen)
      Jancsó, Gábor (Szeged)
      Karádi, Zoltán (Pécs)
      Kovács, László (Debrecen)
      Palkovits, Miklós (Budapest)
      Papp, Gyula (Szeged)
      Pavlik, Gábor (Budapest)
      Spät, András (Budapest)
      Szabó, Gyula (Szeged)
      Szelényi, Zoltán (Pécs)
      Szolcsányi, János (Pécs)
      Szollár, Lajos (Budapest)
      Szücs, Géza (Debrecen)
      Telegdy, Gyula (Szeged)
      Toldi, József (Szeged)
      Tósaki, Árpád (Debrecen)

International Editorial Board

      R. Bauer (Jena)
      W. Benjelloun (Rabat)
      A. W. Cowley Jr. (Milwaukee)
      D. Djuric (Belgrade)
      C. Fry (London)
      S. Greenwald (London)
      O. Hänninen (Kuopio)
      H. G. Hinghofer-Szalkay (Graz)
      Th. Kenner (Graz)
      Gy. Kunos (Richmond)
      M. Mahmoudian (Tehran)
      T. Mano (Seki, Gifu)
      G. Navar (New Orleans)
      H. Nishino (Nagoya)
      O. Petersen (Liverpool)
      U. Pohl (Münich)
      R. S. Reneman (Maastricht)
      A. Romanovsky (Phoenix)
      G. M. Rubanyi (Richmond)
      T. Sakata (Oita)
      A. Siddiqui (Karachi)
      Cs. Szabo (Beverly)
      E. Vicaut (Paris)
      N. Westerhof (Amsterdam)
      L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Physiologica Hungarica
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: aph@semmelweis-univ.hu